Skip to content
  • Sunday, 26 July 2026
  • 1:46 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Stanford Researchers Discover Protein Inhibitor That Reverses Cartilage Loss and Prevents Osteoarthritis
Stem Cell & Regenerative Medicine

Stanford Researchers Discover Protein Inhibitor That Reverses Cartilage Loss and Prevents Osteoarthritis

Dwi Wanna Jul 20, 2026 0

In a breakthrough that could fundamentally alter the treatment landscape for degenerative joint diseases, researchers at Stanford Medicine have identified…

Read More
Stem Cell & Regenerative Medicine

Stanford Researchers Identify Gerozyme Inhibitor That Regenerates Cartilage and Reverses Osteoarthritis Symptoms

Dwi Wanna Jul 13, 2026 0

In a landmark study that could redefine the treatment of degenerative joint diseases, researchers at Stanford Medicine have demonstrated that…

Read More
Stem Cell & Regenerative Medicine

Stanford Medicine Researchers Identify Protein Inhibitor That Regenerates Lost Knee Cartilage and Reverses Osteoarthritis Damage

Dwi Wanna Jun 28, 2026 0

In a landmark study that could redefine the treatment of degenerative joint diseases, a research team led by Stanford Medicine…

Read More
Neuroscience & Brain Research

Restoration of Amygdala Neural Balance Reverses Anxiety and Social Deficits in Breakthrough Study

Rifan Muazin Jun 6, 2026 0

Researchers at the Institute for Neurosciences (IN), a collaborative institution between the Spanish National Research Council (CSIC) and Miguel Hernández…

Read More
Laboratory Automation & Robotics

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Apr 18, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier decision regarding Moderna’s investigational mRNA influenza vaccine (mRNA-1010),…

Read More
Laboratory Automation & Robotics

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Apr 4, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance on Moderna’s innovative mRNA influenza vaccine candidate,…

Read More
Laboratory Automation & Robotics

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Mar 27, 2026 0

In a significant development for vaccine innovation and public health, the U.S. Food and Drug Administration (FDA) has reversed its…

Read More
Laboratory Automation & Robotics

FDA reverses course, agrees to review Moderna’s mRNA flu vaccine

Lana Keisha Mar 20, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance, agreeing to review Moderna’s messenger RNA (mRNA)…

Read More
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace MedicineNew State of Matter Discovered in Ice Giant Interiors Reveals Secrets of Uranus and NeptuneOtsuka Pharmaceutical to Acquire Transcend Therapeutics for Up to $1.225 Billion to Bolster Psychiatric and Neurological PipelineJohns Hopkins Study Reveals Significant Cardiac Weakening and Molecular Changes in Bioengineered Heart Tissues After Month Long Space Station Mission
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ